HC Wainwright & Co. Maintains Buy on Cassava Sciences, Raises Price Target to $131
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Cassava Sciences (NASDAQ:SAVA) and raised the price target from $124 to $131.
May 17, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has maintained a Buy rating on Cassava Sciences and raised the price target from $124 to $131.
The Buy rating and increased price target from a reputable analyst firm like HC Wainwright & Co. is likely to positively impact investor sentiment and drive short-term price appreciation for Cassava Sciences.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100